ArticleFrontiers in oncology2025

Case Report: Simnotrelvir/Ritonavir are effective in shortening the course of prolonged SARS-CoV-2 infection during anti-CD20 maintenance therapy in patients with follicular lymphoma.

Jing Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.